Help For Ragweed Allergy

Thursday, 17 Apr 2014 04:02 PM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink
The U.S. Food and Drug Administration has approved Merck & Co's pollen allergy drug Ragwitek.

The tablet, which is administered by placing it under the tongue, is to treat the short ragweed pollen induced allergic rhinitis.

The approval for Ragwitek comes days after U.S. regulatory approval for Merck's grass pollen allergy drug Grastek.

Merck's Ragwitek will compete with Stallergenes SA's immunotherapy treatment for five types of grass pollen, which was approved by the FDA earlier this month.

© 2014 Thomson/Reuters. All rights reserved.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Drug Fights Antibiotic-Resistant Infection

Saturday, 20 Dec 2014 10:33 AM

Cubist Pharmaceutical drug to treat complicated urinary tract and intra-abdominal infections won U.S. approval on Friday . . .

New Help Against Ovarian Cancer

Friday, 19 Dec 2014 15:48 PM

The U.S. Food and Drug Administration has approved a new drug to treat advanced ovarian cancer, along with a test to ide . . .

Device Makes Blood Transfusions Safer

Wednesday, 17 Dec 2014 13:08 PM

U.S.health regulators on Tuesday approved a device developed by Cerus to reduce the risk of infections in blood plasma t . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved